Market Update: Prepare for August
Technical market indicators are weakening as August approaches. Post Election Year weakness is likely to arise in the next two months.
Friday Investment Talk: Inflation, Water and COVID
ECB waits for 3%+ inflation levels. Water is a hot topic in ESG investing. Markets rebound after COVID related sell off, but small caps going nowhere.
Friday Investment Talk: Federal Reserve Taper, Europe, China, Oil and COVID
The Federal Rerserve is acting. S&P 500 shakes off a COVID scare, while Oil and China make waves for investors.
Friday Investment Talk: Normalcy, Vaccines, UK/EU Metrics, US Bullishness, Whiskey Scam
The world is still far from “normal”, according to the Economist. The UK/EU is waking up after COVID. US investors are bullish. Whiskey cask investment looks like a scam.
Friday Investment Talk: Emerging Markets, Barron’s Big Money Poll, Seasonality
Closer look at Emerging Markets after last years stellar returns. Barrons Big Money looks bullish from the outside only. SaaS is overvalued still.. Seasonality shifts towards small caps. Financial Vulnerability is a hot topic after COVID.
Financial Vulnerability
An ageing population and the COVID pandemic brought attention to the topic of Financial Vulnerability. Power of Attorneys are a good starting point for discussion, but much more needs to be done to protect everyone.
Earnings Commentary: Netflix
App downloads were falling for Netflix during Q1 as people came out of COVID lockdowns. Did the vaccines kill NFLX?
Stock Research: Railroads
Many railroad companies stand to benefit from a new $3 trillion infrastructure stimulus package proposed by US Democrats. Investors are already positioning for this in the option market.
GameStop, Dividend Stocks, SPACs & IPOs, Market Weakness
A love of GameStop (GME), SPACs, and IPOs is matched with disdain for US stocks in general this week. Dividends are supposed to make a comeback in 2021, with GDP growth and an end to COVID.
Trade Idea: Rebound from Overreaction
A high flying medical diagnostics company has investors scared of falling revenue after COVID vaccines become available. The reaction was a strong sell off and now the stock is back on track towards its all time highs.